RA
Resolute Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-9,884
| Closed | -$888K | – | 136 |
|
|
2022
Q1 | $888K | Sell |
9,884
-5,710
| -37% | -$513K | 0.04% | 26 |
|
|
2021
Q4 | $1.75M | Buy |
15,594
+37
| +0.2% | +$4.14K | 0.05% | 17 |
|
|
2021
Q3 | $1.96M | Buy |
15,557
+14
| +0.1% | +$1.76K | 0.27% | 17 |
|
|
2021
Q2 | $2.1M | Buy |
15,543
+85
| +0.5% | +$11.5K | 0.32% | 15 |
|
|
2021
Q1 | $2.07M | Buy |
15,458
+2,900
| +23% | +$388K | 0.28% | 15 |
|
|
2020
Q4 | $1.77M | Buy |
+12,558
| New | +$1.77M | 0.99% | 18 |
|